HeartBeamBEATW 26 FCF Yield % is -35.87 as of Jun. 29, 2026. GuruFocus rates BEATW with a GF Score™ of 26/100. The stock has 2 warning signs investors should review. Among 683 Healthcare Providers & Services companies, HeartBeam ranks worse than 91.95% on this metric.
FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
The historical rank and industry rank for HeartBeam's FCF Yield % or its related term are showing as below:
BEATW'
s FCF Yield % Range Over the Past 10 Years
Min: -35.87 Med: 0 Max: 0
Current: -35.87
BEATW's FCF Yield % is ranked worse than 91.95% of 683
companies
in the Healthcare Providers & Services industry
Industry Median: 1.88
vs BEATW: -35.87
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
HeartBeam FCF Yield % Related Terms
HeartBeam FCF Yield % Historical Data
* Premium members only.
The historical data trend for HeartBeam's FCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, HeartBeam's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
HeartBeam FCF Yield % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, HeartBeam's FCF Yield % distribution charts can be found below:
* The bar in red indicates where HeartBeam's FCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HeartBeam (BEATW) has a FCF Yield % of -35.87 as of Jun. 29, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on HeartBeam and its competitors. According to the industry distribution chart, HeartBeam ranks #628 out of 683 companies in the Healthcare Providers & Services industry, placing it in the top 91.9%.
Is HeartBeam's FCF Yield % too high?
HeartBeam's current FCF Yield % is -35.87. Based on the distribution chart, HeartBeam ranks #628 out of 683 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, HeartBeam has a GF Score™ of 26/100, reflecting its overall financial health beyond just this single metric.
How does HeartBeam's FCF Yield % compare to ONMD and CRVW?
According to the Healthcare Providers & Services industry distribution chart, HeartBeam ranks #628 out of 683 companies for FCF Yield %. This places HeartBeam in the lower half of its industry. The industry median FCF Yield % is 1.88. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Healthcare Providers & Services company?
The median FCF Yield % among Healthcare Providers & Services companies is 1.88, based on 683 companies in the industry. Companies in the top quartile (top 25%) have a FCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on HeartBeam and its competitors. For the Healthcare Providers & Services industry, the median FCF Yield % is 1.88 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. HeartBeam's current FCF Yield % is -35.87. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is HeartBeam stock overvalued right now?
HeartBeam (BEATW) has a current FCF Yield % of -35.87. The current FCF Yield % is -35.87. HeartBeam's overall GF Score™ is 26/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For HeartBeam (BEATW), the current FCF Yield % is -35.87 as of Jun. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
HeartBeam Inc is a medical technology company focused on developing higher resolution ambulatory electrocardiogram (ECG) solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The company's proprietary and patented technology platform captures the heart's electrical activity from three dimensions and synthesizes a 12-lead ECG from these signals. The company has received U.S. Food and Drug Administration (FDA) clearance for its ECG solutions.
26GF Score
Get the complete analysis for BEATW
FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BEATW has been successfully added to your 
